SNTA LONG
The market isn't seeing SNTA's true potential. This stock is deeply undervalued at the moment. A true price range it should trade at would be $1.10 - $ 1.75 in the medium term even without any effects of expected positive news. SNTA's merger with Madrigal Pharma is also being discounted, while in actual fact it's a great combination, the management details would stand testament to that.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.